Free press releases distribution network?

Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Frost & Sullivan Recognizes Transport Pharmaceuticals Innovative Electrokinetic Drug Delivery Platform - 2007 North American Technology Innovation of the Year Award in electrokinesis-enabled drug delivery in recognition of its development of a unique platform technology
Frost & Sullivan Recognizes Transport Pharmaceuticals Innovative Electrokinetic Drug Delivery Platform

 

PRZOOM - /newswire/ - Palo Alto, CA, United States, 2007/12/10 - 2007 North American Technology Innovation of the Year Award in electrokinesis-enabled drug delivery in recognition of its development of a unique platform technology.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Frost & Sullivan has presented Transport Pharmaceuticals, Inc. with the 2007 North American Technology Innovation of the Year Award in electrokinesis-enabled drug delivery in recognition of its development of a unique platform technology that enhances the delivery of topically applied drugs and the utility of potent systematically delivered drugs.

"Founded in 1999, this privately held, venture-backed specialty pharmaceutical company based in Massachusetts is revolutionizing the treatment of dermal diseases by bringing together cutting-edge medical electronics with advanced drug formulation and material sciences to develop combination drug-device products," stated Frost & Sullivan Industry Analyst Pramodh Ishwarakrishnan.

Transport Pharmaceuticals' lead product, the SoloVir™ Electrokinetic Transdermal System (SoloVir™ ETS), represents a significant breakthrough in the treatment of herpes labialis or cold sores by enabling drug delivery via a small handheld device and a unit dose disposable medication applicator.

Using a small wireless reusable microprocessor-controlled drug delivery unit that fits onto a finger, and a pre-filled drug reservoir cartridge, this combination drug/device system allows patients to self-administer a drug for a variety of indications.

The system is capable of delivering 100 times more acyclovir (a leading topical antiviral drug) directly into the skin area than currently available treatment options, and requires only one painless, ten-minute treatment application.

"Capitalizing on electrokinetic drug delivery, the SoloVir™ ETS eliminates the concomitant problems of pain, trauma, and the risk of patient infection," says Ishwarakrishnan. "Human trials have been performed for SoloVir™ ETS and the technology has been validated in several U.S. clinical trials in over 1000 patients."

Patent applications have been filed for the SoloVir™ ETS, including the company's novel acyclovir formulation, the device and the drug cartridge. Sixty-five applications of the technology are under review and the company, to date, has been granted 13 U.S. patents and 11 international patents.

Transport Pharmaceuticals, Inc. outsources manufacturing of the drug and the device but ensures quality through its in-house engineering, regulatory and quality affairs groups who work closely with vendors to integrate their processes into Transport's quality systems. The business model provides the flexibility and the necessary cost savings of a "virtual" model and helps ensure the timely and quality performance by vendors.

The company has also had considerable success in attracting venture capital investment, a fact that positively reflects on the promise of the company's technology. It has raised a total of $36 million from highly regarded VC's, such as the Carlyle Group, Quaker Bioventures and the Hillman Company.

Each year, Frost & Sullivan's Technology Innovation of the Year Award is bestowed upon a company that has carried out new research, which has resulted in innovations that are expected to bring significant contributions to the industry in terms of adoption, change, and competitive.

posture. This Award recognizes the quality and depth of a company's research and development program as well as the vision and risk-taking that enabled it to undertake such an endeavor.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Transport Pharmaceuticals, Inc.
Transport is a specialty pharmaceutical company revolutionizing the treatment of dermal diseases by bringing together cutting edge medical electronics, drug formulation and materials science to develop novel drug/device combination products. This unique combination of technologies can enhance the delivery of topically applied drugs and the utility of potent systemically delivered drugs whose uses are limited by bio-availability, toxicity or side effect concerns.

About Frost & Sullivan
Frost & Sullivan, the Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Metropolitan Area

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Recognizes Transport Pharmaceuticals Innovative Electrokinetic Drug Delivery Platform

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Melina Trevino 
210.247.2440 melina.trevino[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Frost & Sullivan / Company Profile


Read Medical Services/Equipment Most Recent Related Press Releases:

PMR Releases Report for Next Generation IV Infusion Pumps Market Impact of Existing and Emerging Market 2017-2025
Medical Tapes Market to Reach US$ 2Bn by 2024 Reports PMR
Global Pyrogen Testing Market Value Expected to Increase to US$ 1.37 Billion by 2024 Says PMR
Huber Needles Market Expected to Reach US$ 55M by 2024 According to PMR
ZOLL Technologies for Improving CPR Quality to be Showcased at NTI 2017
ConfirmMDx Improves Prostate Cancer Diagnosis in African American Men
Biomarker-based Technologies to Disrupt Conventional Diagnosis in Diabetes Management across the Globe Finds Frost & Sullivan
Agfa Specialty Products Announces the Launch of UNIQOAT
Sparta Releases Stratas 3.0 and TrackWise Intake
GE Healthcare Signs Agreement with HealthTrust to Supply Radiopharmaceuticals

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  MagLar, Inc.

Visit  BizJobs.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today